Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.
Disingenuous. Can you name a vaccine that does either or both? What vaccines do is sensitise your immune system against a 'real' infection that you have not yet met, in effect simulating a natural disease with a less-dangerous 'artificial' version. This means that, when you meet the 'real' thing you will mount not a primary (=slow) immune response but a much faster and stronger (=secondary) immune response. So you become less ill. A vaccine does not prevent you being infected with the real disease, nor does it prevent you either infecting nor becoming infected by others. So, while it is true that no vaccine 'stops' spread or infection by its primary effect, they reduce the effects of an infection and, by doing so, may have consequences upon both (eg by getting on top of an infection rapidly, because of strong secondary response, there may be fewer transmissible virus/bacterium particles to infect others). Hope that helps.
Of course. One of my rules-of-thumb, almost always proved right with patience. Big price decline on low volume = someone knows good news is afoot and wants to get in lower, usually lots of Auto trades so not private individuals, so wait for the good news and don't bother selling. Big price decline on large volumes = yes, probably something is wrong and you might as well sell and d something else with the money. Works for me.
Trouble is, anything that has debt and no earnings is getting hammered short to medium term right now, anticipating significantly higher loan repayments (and/or fundraising) over the next few years. That obviously includes a great many tech and biotech companies. Until the big investors see income to cover debt arriving we may be in for some biotech gloom. Hopefully Scancell and some others can show the numbers, over the next few months, to stop disinvestment happening else my spreadsheets are going to look pretty dark.
90 mins to a verdict...